QuickView for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=9A293F9B4FD554D3CFAA1B9898B171E8;jsessionid=C8B5755C1AB667BEC9CC28337B057DA7;jsessionid=9A6DB3B64EC4691E87DB5822539F917C;jsessionid=7AF65381BB3D62F021DDA5BDBA8718D5;jsessionid=605E7746CF3A512AF84EB8CDA100011E;jsessionid=B117FDB091148715CE4AE12D1A309E26;jsessionid=1B0EA0F9BF66AA091C20D14C3B9E1F93 (gene)

1. Thymic stroma and TFII-I: towards new targeted therapies.
2. Proteomic analysis of SRF associated transcription complexes identified TFII-I as modulator of SRF f…
3. Structural basis for evolutionarily conserved interactions between TFIIS and Paf1C.
4. The TFIIS N-terminal domain (TND): a transcription assembly module at the interface of order and dis…
5. Identification of novel regulatory NFAT and TFII-I binding elements in the calbindin-D28k promoter i…

There were no clinical trials for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=9A293F9B4FD554D3CFAA1B9898B171E8;jsessionid=C8B5755C1AB667BEC9CC28337B057DA7;jsessionid=9A6DB3B64EC4691E87DB5822539F917C;jsessionid=7AF65381BB3D62F021DDA5BDBA8718D5;jsessionid=605E7746CF3A512AF84EB8CDA100011E;jsessionid=B117FDB091148715CE4AE12D1A309E26;jsessionid=1B0EA0F9BF66AA091C20D14C3B9E1F93